Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$30.43 - $53.43 $203,089 - $356,591
6,674 New
6,674 $268,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $2,231 - $3,517
-51 Reduced 61.45%
32 $2,000
Q2 2022

Aug 08, 2022

BUY
$53.22 - $123.09 $1,756 - $4,061
33 Added 66.0%
83 $5,000
Q1 2022

May 10, 2022

SELL
$101.89 - $150.09 $611 - $900
-6 Reduced 10.71%
50 $6,000
Q4 2021

Feb 11, 2022

BUY
$118.18 - $153.21 $4,490 - $5,821
38 Added 211.11%
56 $8,000
Q3 2021

Nov 08, 2021

BUY
$93.51 - $129.4 $1,683 - $2,329
18 New
18 $2,000
Q1 2021

Apr 28, 2021

SELL
$81.28 - $104.34 $162 - $208
-2 Closed
0 $0
Q3 2020

Nov 02, 2020

SELL
$95.43 - $116.09 $465,316 - $566,054
-4,876 Reduced 99.96%
2 $0
Q2 2020

Aug 11, 2020

BUY
$60.05 - $98.92 $259,596 - $427,631
4,323 Added 778.92%
4,878 $482,000
Q1 2020

May 15, 2020

BUY
$47.37 - $90.04 $26,290 - $49,972
555 New
555 $36,000
Q4 2019

Feb 13, 2020

SELL
$53.13 - $71.19 $47,551 - $63,715
-895 Closed
0 $0
Q3 2019

Oct 17, 2019

SELL
$57.11 - $73.3 $124,728 - $160,087
-2,184 Reduced 70.93%
895 $52,000
Q2 2019

Aug 05, 2019

SELL
$54.41 - $71.7 $75,956 - $100,093
-1,396 Reduced 31.2%
3,079 $199,000
Q1 2019

Apr 16, 2019

BUY
$32.25 - $73.56 $14,706 - $33,543
456 Added 11.35%
4,475 $284,000
Q4 2018

Jan 17, 2019

BUY
$28.45 - $40.65 $37,269 - $53,251
1,310 Added 48.36%
4,019 $152,000
Q3 2018

Nov 02, 2018

BUY
$21.39 - $51.17 $55,079 - $131,762
2,575 Added 1921.64%
2,709 $0
Q2 2018

Jul 24, 2018

SELL
$4.9 - $23.64 $3,111 - $15,011
-635 Reduced 82.57%
134 $0
Q1 2018

May 03, 2018

SELL
$2.35 - $4.96 $227 - $481
-97 Reduced 11.2%
769 $4,000
Q4 2017

Feb 02, 2018

BUY
$2.24 - $8.2 $1,939 - $7,101
866
866 $2,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $1.98B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.